[Radiotherapy versus radiotherapy plus hormone therapy in the case of isolated PSA increase after radical prostatectomy. A prospective multicenter Phase III study of the AUO (AP 26/99) and the ARO (00/01)].
Schwarz
R
R
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. rschwarz@uke.uni-hamburg.de
Rexer
H
H
D017024:Chemotherapy, Adjuvant / Q000706:statistics & numerical data; D005858:Germany / Q000453:epidemiology; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018365:Neoplasm, Residual / Q000097:blood / Q000453:epidemiology* / Q000628:therapy*; D011446:Prospective Studies; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000706:statistics & numerical data*; D011471:Prostatic Neoplasms / Q000097:blood / Q000453:epidemiology* / Q000628:therapy*; D011878:Radiotherapy / Q000706:statistics & numerical data*; D016896:Treatment Outcome
D006728:Hormones; D017430:Prostate-Specific Antigen